Prevention of Atrial Fibrillation by Bucindolol Is Dependent on the Beta(1)389 Arg/Gly Adrenergic Receptor Polymorphism

OBJECTIVES: This study assessed the impact of bucindolol, a beta-blocker/sympatholytic agent, on the development of atrial fibrillation (AF) in advanced chronic heart failure with reduced left ventricular ejection fraction (HFREF) patients enrolled in the BEST (Beta-Blocker Evaluation of Survival Tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Aleong, Ryan G., Sauer, William H., Davis, Gordon, Murphy, Guinevere A., Port, J. David, Anand, Inder S., Fiuzat, Mona, O’Connor, Christopher M., Abraham, William T., Liggett, Stephen B., Bristow, Michael R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804380/
https://ncbi.nlm.nih.gov/pubmed/24159564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2013.04.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados